Study
Degradation of Cyclin K/CDK12 is a druggable vulnerability of colorectal cancer (H012)
| Study ID | Alternative Stable ID | Type |
|---|---|---|
| EGAS00001004517 | Cancer Genomics |
Study Description
Study Datasets 5 datasets.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001006263 |
linking 3 samples out of EGAD00001002528 to EGAS0001004517
|
Illumina HiSeq 2000 | 3 |
| EGAD00001006264 |
18 samples of RNA-Seq of serially passaged TIC-enriched spheres of colorectal cancer (CRC), sequenced on HiSeq2000 and HiSeq2500
|
Illumina HiSeq 2500 | 8 |
| EGAD00001006265 |
WGS data of serially passaged TIC-enriched spheres of colorectal cancer
|
HiSeq X Ten | 6 |
| EGAD00001006266 |
WES data of serially passaged TIC-enriched spheres of colorectal cancer (CRC)
|
Illumina HiSeq 2000,Illumina HiSeq 2500 | 15 |
| EGAD00010001936 |
Gene expression of 12 colon cancer TSCs (sensitive or resistant) after 12h treatment with 3µM NCT02 or DMSO (control) was analyzed using Illumina microarrays (HumanHT-12 v4 BeadChip).
|
oligonucleotide beads of HumanHT-12 V4 R2 Expression BeadChips (Illumina) | 24 |
Who archives the data?
